<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04108182</url>
  </required_header>
  <id_info>
    <org_study_id>BIOMS-POAHF</org_study_id>
    <nct_id>NCT04108182</nct_id>
  </id_info>
  <brief_title>A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)</brief_title>
  <official_title>A Registry Study of Biomarkers in Progression of Acute Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Institute of Heart, Lung and Blood Vessel Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Institute of Heart, Lung and Blood Vessel Diseases</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The registry study aims to discover the prognostic value of bio-markers in acute heart
      failure
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">October 2025</completion_date>
  <primary_completion_date type="Anticipated">August 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of death ( all cause) or readmission for heart failure</measure>
    <time_frame>a median follow-up of 8.8 months</time_frame>
    <description>Number of Death or heart failure related hospitalization within a median follow-up of 8.8 months of discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of death ( all cause) or readmission for heart failure and cardiovascular mortality</measure>
    <time_frame>a median follow-up of 8.8 months</time_frame>
    <description>Number of Death or heart failure related hospitalization and cardiovascular mortality within a median follow-up of 8.8 months of discharge</description>
  </secondary_outcome>
  <enrollment type="Anticipated">850</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood Samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with heart failure accorrding to Inclusion and exclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Patients aged greater than or equal to 18 years with acute exacerbation of chronic
             heart failure or new heart failure

          -  2. With typical symptoms of acute heart failure as follows: Dyspnea, ankle swelling
             and fatigue (Limited activity endurance), increased jugular pressure, rales and
             peripheral edema ;

          -  3. Plasma concentrations of BNP: BNP&gt;100pg/ML

          -  4. Echocardiography: Related structural heart disease (left ventricular hypertrophy
             and/or left atrial enlargement) and/or diastolic dysfunction

        Exclusion Criteria:

          -  1. Previous history of cancer or renal replacement therapy

          -  2.Surgery was performed within a month

          -  3.Accompanied by cardiogenic shock, sepsis, pneumonia

          -  4.Eligible patients without informed consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jie Du, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Anzhen Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yulin Li, PHD</last_name>
    <email>lyllyl_1111@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ke-xu Yang</last_name>
      <phone>86-010-64426153</phone>
      <email>EC@anzhenGCP.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>September 26, 2019</last_update_submitted>
  <last_update_submitted_qc>September 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

